Why One-Size-Fits-All IVF Protocols Don’t Work
Our Team
5/28/2026
Why One-Size-Fits-All IVF Protocols Don’t Work
At the Center for Human Reproduction (CHR), we believe IVF protocols should be individualized based on each patient’s biology, ovarian reserve, hormone levels, age, and treatment history. A standardized approach may work for some patients. However, for many, especially women over 40, patients with diminished ovarian reserve (DOR), or those with prior IVF failures, it can overlook differences that impact the chances of pregnancy.
No two people are exactly alike, and modern medicine is increasingly recognizing the importance of individualized care through what is known as precision medicine. Originally developed in oncology, the concept has expanded into many other areas of healthcare, including infertility, where personalized treatment approaches can play a critical role in improving outcomes.
CHR has long focused on personalized IVF care, tailoring treatment plans to each individual patient.
Individualized IVF treatment may include:
- Customized medication protocols
- Adjustments during stimulation cycles
- Personalized egg retrieval timing
- Tailored embryo transfer decisions
- Different strategies for PCOS, DOR, or recurrent IVF failure
For many patients, failed IVF cycles are not necessarily a sign that IVF cannot work. They may simply indicate that the treatment protocol was not the right fit for them. Fertility treatment is not one-size-fits-all, and successful IVF often depends on recognizing that every patient’s path to pregnancy is different.
If you're interested in learning more, click the video below!
Recent Posts
Understanding DOR, POA, and POI
Diminished Ovarian Reserve (DOR), Premature Ovarian Aging (POA) and Primary Ovarian Insufficiency (POI): What Is the Difference and Why It Matters?
Natural Cycle IVF vs Stimulated Cycles
When considering IVF, many people are surprised to learn that there is more than one way to approach treatment.
What We've Learned From Transferring "Abnormal" Embryos
For many years, embryos identified as "abnormal" were considered unsuitable for transfer. Today, growing evidence has changed that perspective.